
### [Orphanet:98372](http://www.orpha.net/ORDO/Orphanet_98372)
**Label:** Hemolytic anemia due to a disorder of glycolytic enzymes

**Subclasses:** [Orphanet:371](http://www.orpha.net/ORDO/Orphanet_371) (Glycogen storage disease due to muscle phosphofructokinase deficiency), [Orphanet:90031](http://www.orpha.net/ORDO/Orphanet_90031) (Non-spherocytic hemolytic anemia due to hexokinase deficiency), [Orphanet:868](http://www.orpha.net/ORDO/Orphanet_868) (Triose phosphate-isomerase deficiency), [Orphanet:713](http://www.orpha.net/ORDO/Orphanet_713) (Glycogen storage disease due to phosphoglycerate kinase 1 deficiency), [Orphanet:714](http://www.orpha.net/ORDO/Orphanet_714) (Hemolytic anemia due to diphosphoglycerate mutase deficiency), [Orphanet:766](http://www.orpha.net/ORDO/Orphanet_766) (Hemolytic anemia due to red cell pyruvate kinase deficiency), [Orphanet:712](http://www.orpha.net/ORDO/Orphanet_712) (Hemolytic anemia due to glucophosphate isomerase deficiency), [Orphanet:57](http://www.orpha.net/ORDO/Orphanet_57) (Glycogen storage disease due to aldolase A deficiency), [Orphanet:466026](http://www.orpha.net/ORDO/Orphanet_466026) (Class I glucose-6-phosphate dehydrogenase deficiency), 

**Corr. equiv. classes:** [Orphanet:57](http://www.orpha.net/ORDO/Orphanet_57), [OMIM:222800](http://purl.obolibrary.org/obo/OMIM_222800), [Orphanet:371](http://www.orpha.net/ORDO/Orphanet_371), [OMIM:300653](http://purl.obolibrary.org/obo/OMIM_300653), [OMIM:613470](http://purl.obolibrary.org/obo/OMIM_613470), [OMIM:266200](http://purl.obolibrary.org/obo/OMIM_266200), [OMIM:235700](http://purl.obolibrary.org/obo/OMIM_235700), [OMIM:611881](http://purl.obolibrary.org/obo/OMIM_611881), [OMIM:300908](http://purl.obolibrary.org/obo/OMIM_300908), [OMIM:232800](http://purl.obolibrary.org/obo/OMIM_232800), [OMIM:615512](http://purl.obolibrary.org/obo/OMIM_615512), [Orphanet:713](http://www.orpha.net/ORDO/Orphanet_713), [Orphanet:712](http://www.orpha.net/ORDO/Orphanet_712), [Orphanet:714](http://www.orpha.net/ORDO/Orphanet_714), [Orphanet:868](http://www.orpha.net/ORDO/Orphanet_868), [Orphanet:90031](http://www.orpha.net/ORDO/Orphanet_90031), [Orphanet:466026](http://www.orpha.net/ORDO/Orphanet_466026), [Orphanet:766](http://www.orpha.net/ORDO/Orphanet_766), 

**Class expressions from DL-Learner:**

- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0001082](http://purl.obolibrary.org/obo/HP_0001082) (Cholecystitis) and [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) 66.67%


